CCCarlo Castellani

Carlo Castellani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Carlo Castellani has a total of 92 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • An Interactive Computer Program Can Effectively Educate Potential Users of Cystic Fibrosis Carrier Tests

    by Carlo Castellani, Sandra Perobelli, Vera Bianchi, Manuela Seia, Paola Melotti, Luisa Zanolla, Baroukh Maurice Assael, Faustina Lalatta

    A Consensus Statement (Genetic Testing for Cystic Fibrosis, NIH Consensus Statement, 1997) concluded that carrier testing for cystic fibrosis (CF) should be offered not only to adults who are at increased reproductive risk due to a positive family history of CF but also to their partners and to couples from the general population planning a pregnancy. Subsequently, several professional medical organizations issued similar recommendations for widespread genetic testing for CF. Education of any individual planning to undergo genetic testing on the nature of the disease, risk of genetic transmission, and the test itself is best achieved with a face-to-face genetic counseling (GC) session. However, GC is costly, time-consuming, and there are too few trained professionals to meet the demand for testing. With the continuing increase in the number of genetic tests available for clinical use, alternative educational and counseling methods are needed. Although health education materials such as booklets and videotapes are available, these are of limited value because the information provided is inadequate and they do not allow for interaction with the end user. In recent years, an interactive computer-based (IC) program has shown effectiveness for providing adequate information to individuals who were undergoing testing for a genetic disease or were scheduled for a medical or surgical procedure. This interventional randomized clinical trial compared the efficacy of the IC program and a traditional GC session to educate potential users of the CF carrier test about the disease and benefits and limitations of carrier testing. Individuals undergoing an assisted reproduction protocol were randomly assigned to participate either in an IC-assisted session (n = 22) or a GC session (n = 22). A multiple-choice questionnaire was administered both before and after the educational intervention to assess improvements among the participants regarding knowledge and understanding of several issues related to CF carrier testing. The study was conducted for a period of 1 year, starting in 2008. The precounseling knowledge level (baseline) was similar in both groups (IC group: 45% vs. GC group: 47%). After the counseling sessions, there was a statistically significant improvement from baseline in the proportion of correct answers in each group (P < 0.0001 for both), but no difference was found between the groups in the number of correct answers (85% in the IC group and 84% in the GC group). None of the participants in either group changed their intention to undergo testing. These findings show that interactive education by computer is as effective an educational tool for potential users of the CF carrier test as individual face-to-face counseling.

  • Evaluation of the Disease Liability of CFTR Variants

    by Patrick R. Sosnay, Carlo Castellani, Mary Corey, Ruslan Dorfman, Julian Zielenski, Rachel Karchin, Christopher M. Penland, Garry R. Cutting

    Over 1600 novel sequence variants in the CFTR gene have been reported to the CF Mutation Database (http://www.genet.sickkids.on.ca/cftr/Home.html). While about 25 mutations are well characterized by clinical studies and functional assays, the disease liability of most of the remaining mutations is either unclear or unknown. This gap in knowledge has implications for diagnosis, therapy selection, and counseling for patients and families carrying an uncharacterized CFTR mutation. This chapter will describe a critical approach to assessing the disease implications of CFTR mutations utilizing clinical data, literature review, functional testing, and bioinformatic in silico methods.


  • Open Access

    Association Between Carrier Screening and Incidence of Cystic Fibrosis

    by Carlo Castellani, Luigi Picci, Anna Tamanini, Paolo Girardi, Paolo Rizzotti, Baroukh Maurice Assael

    Quiz Ref ID Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the CF transmembrane regulator (CFTR) gene (RefSeq NM_000492).1 In Europe, the median birth incidence of CF is 1 in 3500.2 Fluctuations in the number of annual CF births have been repeatedly reported,3-5 and some studies suggest a progressive decrease in CF birth incidence.3,6 However, these trends were recorded in populations diagnosed because of symptoms and are subject to ascertainment bias. The number of diagnoses may be incomplete for recent years, because patients may not yet be diagnosed or some patients could be lost before they are diagnosed. Incidence may be better appreciated when the analysis is performed on CF populations diagnosed through neonatal screening programs.


  • European best practice guidelines for cystic fibrosis neonatal screening

    by Carlo Castellani, Kevin W. Southern, Keith Brownlee, Jeannette Dankert Roelse, Alistair Duff, Michael Farrell, Anil Mehta, Anne Munck, Rodney Pollitt, Isabelle Sermet-Gaudelus, et al.


  • Top Cited Papers

    Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice

    by C. Castellani, H. Cuppens, M. Macek, J.J. Cassiman, E. Kerem, P. Durie, E. Tullis, B.M. Assael, C. Bombieri, A. Brown, et al.


  • TG15 T5 allele in clinically discordant monozygotic twins with cystic fibrosis

    by Luigi Picci, Marilena Cameran, Maurizio Scarpa, Ugo Pradal, Paola Melotti, Baroukh M. Assael, Carlo Castellani


  • The genetic background of osteoporosis in cystic fibrosis: Association analysis with polymorphic markers in four candidate genes

    by Carlo Castellani, Giovanni Malerba, Antonella Sangalli, Antonella Delmarco, Elena Petrelli, Maurizio Rossini, Baroukh M. Assael, Monica Mottes